HIGHLIGHTS
- who: Fábio França and colleagues from the University Institute of Health Sciences (IUCS), Rua Central de Gandra, , Gandra, Portugal have published the research: A Pyranoxanthone as a Potent Antimitotic and Sensitizer of Cancer Cells to Low Doses of Paclitaxel, in the Journal: (JOURNAL)
- what: The authors report the mechanism elucidation of the lead compound pyranoxanthone 2, identified as a lead compound with potent cytotoxic activity against cancer cells, and determined its potential to increase the sensitivity of cancer cells to low doses of paclitaxel.
- how: The authors evaluated whether the compound . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.